The Los Angeles-based venture capital firm was founded in 2018 and focuses on investing in scientific teams pursuing ambitious goals in the fields of immunotherapy, gene therapy/genetic engineering, organ engineering, and stem cell/regenerative medicine. Tachyon Ventures seeks out companies with world-leading research and secured IP, providing them with the necessary funding to bring their innovative ideas to life and make a significant impact on the world of medicine.